{
    "2018-03-16": [
        [
            {
                "time": "",
                "original_text": "沃森生物子公司新药获批临床研究 有望治疗部分乳腺癌",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "新药",
                        "临床研究",
                        "乳腺癌"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强烈推荐评级] 沃森生物(300142)事件点评：单抗药物再获临批 研发实力再次获得证明",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "单抗药物",
                        "临床批准",
                        "研发实力"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业:看好创新药与一致性评价领域龙头白马",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新药",
                        "一致性评价",
                        "龙头白马"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}